Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists ... primarily because of ...

A mum is warning people not to take skinny jabs from 'strangers on the internet' - after nearly dying when she accidentally injected 'five times' the recommended dose sent as a 'freebie' over ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

When you need to work with the health care provider you have, here’s how to advocate for yourself, even while wearing a skimpy gown.

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes medication ... View this interactive chart on Fortune.com For ...